Results 31 to 40 of about 28,111,627 (303)
The outbreak of the coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 triggered a global pandemic where control is needed through therapeutic and preventive interventions. This study aims to identify natural compounds
Tomokazu Ohishi +6 more
doaj +3 more sources
Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
Background The etiological agent for the coronavirus illness outbreak in 2019–2020 is a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19), whereas coronavirus disease pandemic of 2019 (COVID-19) has ...
Soumya Gulab Katre +6 more
doaj +1 more source
Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2 [PDF]
The first laboratory confirmed case of Coronavirus disease 2019 (COVID-19) in Australia was in Victoria on 25 January 2020 in a man returning from Wuhan city, Hubei province, the People's Republic of China. This was followed by three cases in New South Wales the following day.
Gulholm, T. +4 more
openaire +4 more sources
Autophagy in severe acute respiratory syndrome coronavirus 2 infection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) orchestrates host factors to remodel endomembrane compartments for various steps of the infection cycle. SARS-CoV-2 also intimately intersects with the catabolic autophagy pathway during infection.
Chen, Di, Zhang, Hong
openaire +2 more sources
Secretion of severe acute respiratory syndrome coronavirus 2 in urine [PDF]
Purpose of review Despite the plethora of publications discussing the severe respiratory coronavirus 2 (SARS-CoV-2), evidence of viral secretion in urine is sparse. Recent findings We could identify 34 publications including a total of 2172 patients.
Brönimann S. +5 more
openaire +2 more sources
Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in children generally have milder presentations, but severe disease can occur in all ages. MIS-C and persistent post-acute COVID-19 symptoms can be experienced by children with previous infection and emphasize the need for infection prevention. Optimal treatment for COVID-19 is not
Chow, Eric J., Englund, Janet A.
openaire +2 more sources
In Utero Severe Acute Respiratory Syndrome Coronavirus 2 Infection [PDF]
Abstract Evidence for in utero transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is growing but not definitive. We present a case of neonatal infection that supports in utero transmission of SARS-CoV-2 and provides insight into the hematogenous spread from mother to fetus.
Von Kohorn, Isabelle +11 more
openaire +2 more sources
Findings of Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection [PDF]
Liver injury due to coronavirus disease 2019 (COVID-19) is being increasingly recognized. Abnormal liver chemistry tests of varying severities occur in a majority of patients. However, there is a dearth of accompanying liver histologic studies in these patients.The current report details the clinical courses of 2 patients having severe COVID-19 ...
Fiel, M. Isabel +11 more
openaire +3 more sources
Molecular mechanisms of severe acute respiratory syndrome (SARS) [PDF]
Severe acute respiratory syndrome (SARS) is a new infectious disease caused by a novel coronavirus that leads to deleterious pulmonary pathological features.
David A Groneberg +6 more
core +2 more sources
Objectives: Recent studies after the outbreak of coronavirus disease 2019 have shown an association of the ABO blood group to the susceptibility of severe acute respiratory syndrome coronavirus 2 infection.
Sanyukta Gurung +8 more
doaj +1 more source

